CLINICAL_TRIALS
trial_result
· 2016-07-26
Clinical Trial Update: The Effect of Ruboxistaurin on Small Fiber Function [Phase 2]
Summary
A Phase 2 trial evaluated ruboxistaurin for small fiber function in diabetic neuropathy. The trial is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chromaderm, Inc. | Conditions: Diabetic Neuropathy | Phase 2 | Status: COMPLETED